Gabapentin-associated hepatotoxicity [18]

American Journal of Gastroenterology

Volumn 96, Issue 12, 2001, Pages 3460-3462

  Lasso De La Vega, Maria C ^a   Zapater, Pedro ^a   Such, Jose ^a,b   Pérez Mateo, Miguel ^a,b   Horga, Jose F ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CIPROFLOXACIN; CLONAZEPAM; DEXCHLORPHENIRAMINE; DIPYRONE; FENTANYL; GABAPENTIN; METHYLPREDNISOLONE; MORPHINE; OMEPRAZOLE; TRAMADOL;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG ABSORPTION; DRUG TOLERANCE; HUMAN; LETTER; LIVER TOXICITY; MALE; PRIORITY JOURNAL; SKIN TOXICITY;

EID: 0035660168     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03919-3     Document Type: Letter

References (7)

1. Enzyme induction and inhibition by new anti-epileptic drugs: A review of human studies
2. Adverse reactions to new anticonvulsant drugs
3. Side effects of add-on gabapentin in individuals with epilepsy, mental retardation, and developmental disabilities
4. Toward the operational identification of adverse drug reactions
5. e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables
6. Possible ciprofloxacin-induced acute cholestatic jaundice
7. Treatment of seizures in acute intermittent porphyria: Safety and efficacy of gabapentin